Change in mortality rates of respiratory disease during the COVID-19 pandemic

References

• ZaimS, ChongJH, SankaranarayananV, etal. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45(8):100618.
   PubMed Web of Science ®Google Scholar
• KhanIH, ZahraSA, ZaimS, etal. At the heart of COVID-19. JCard Surg. 2020;35(6):1287–1294.
   Web of Science ®Google Scholar
• Jiangsu Provincial People’s Government. Jiangsu Province initiates first-level response to public health emergencies [Internet, in Chinese]; 2020 [cited 2020 May 29]. Available from: http://www.jiangsu.gov.cn/art/2020/1/24/art_60095_8956402.html.
   Google Scholar
• Jiangsu Provincial People’s Government. Jiangsu epidemic prevention and control has been adjusted from provincial secondary response to tertiary response [Internet, in Chinese]; 2020 [cited 2020 Jun 2]. Available from: http://www.jiangsu.gov.cn/art/2020/3/28/art_60096_9026596.html.
   Google Scholar
• NicolaM, AlsafiZ, SohrabiC, etal. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. IntJSurg. 2020;78:185–193.
   Google Scholar
• HsiangS, AllenD, Annan-PhanS, etal. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820): 262–267.
   PubMed Web of Science ®Google Scholar
• SorianoJB, KendrickPJ, PaulsonKR. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: asystematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596.
   PubMed Web of Science ®Google Scholar
• LiX, ZhangX, eds. 2019. The death surveillance data set in China, 2018. 1rd. in Chinese Beijing:Popular Science Press, Publishers.
   Google Scholar
• WangL, DongJ, SongG, eds. 2017. Guidance manual on population cause of death monitoring. 1rd. in Chinese Beijing:China Population Press, Publishers.
   Google Scholar
• GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: asystematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788.
   PubMed Web of Science ®Google Scholar
• YuX. Assessing Epidemic Trend in Real Time with a Simple Ratio Plot. Am J Epidemiol. 2020;189(11):1438–1441.
   Google Scholar
• KuoSC, ShihSM, ChienLH, etal. Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerg Infect Dis. 2020;26(8):1928–1930.
   PubMed Web of Science ®Google Scholar
• Perez-LopezA, HasanM, IqbalM, etal. Dramatic decrease of laboratory-confirmed influenza Aafter school closure in response to COVID-19. Pediatr Pulmonol.2020;55(9):2233–2234.
   PubMed Web of Science ®Google Scholar
• ZipfelCM, BansalS. Assessing the interactions between COVID-19 and influenza in the United States. medRxiv : The Preprint Server for Health Sciences. 2020; published online ahead of print Apr1, 2020. DOI:10.1101/2020.03.30.20047993
   PubMedGoogle Scholar
• ItayaT, FuruseY, JindaiK. Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020. IntJInfect Dis. 2020;97:78–80.
   Web of Science ®Google Scholar
• LeeH, LeeH, SongKH, etal. Impact of public health interventions on seasonal influenza activity during the SARS-CoV-2 outbreak in Korea. Clin Infect Dis. 2020;30:ciaa672.
   Google Scholar
• SooRJJ, ChiewCJ, MaS, etal. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg Infect Dis. 2020;26(8):1933–1935.
   PubMed Web of Science ®Google Scholar
• ZhengJ, PengZ, QinY, etal. Current situation and challenges on the implementation of prevention and control programs regarding the seasonal influenza, in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(8):1041–1044.in Chinese
   PubMedGoogle Scholar
• LiL, LiuY, WuP, etal. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019;4(9):e473–481.
   PubMed Web of Science ®Google Scholar
• IulianoAD, RoguskiKM, ChangHH, etal. Estimates of global seasonal influenza-associated respiratory mortality: amodelling study. Lancet. 2018;391(10127):1285–1300.
   PubMed Web of Science ®Google Scholar
• WangJ, PanL, TangS, etal. Mask use during COVID-19: arisk adjusted strategy. Environ Pollut. 2020;266(Pt 1):115099.
   PubMedGoogle Scholar
• FengS, ShenC, XiaN, etal. Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med. 2020;8(5):434–436.
   PubMed Web of Science ®Google Scholar
• WHO. Shortage of personal protective equipment endangering health workers worldwide [Internet]; 2020 [cited 2020 Mar 3]. Available from:. https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide.
   Google Scholar
• EikenberrySE, MancusoM, IboiE, etal. To mask or not to mask: modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model. 2020;5:293–308.
   PubMedGoogle Scholar
• HassanSA, SheikhFN, JamalS, etal. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 2020;12(3):e7355.
   PubMed Web of Science ®Google Scholar
• ZhaiP, DingY, WuX, etal. The epidemiology, diagnosis and treatment of COVID-19. IntJAntimicrob Agents. 2020;55(5):105955.
   PubMed Web of Science ®Google Scholar
• CabriniL, LandoniG, ZangrilloA. Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet. 2020;395(10225):685.
   PubMed Web of Science ®Google Scholar
• HeY, LiW, WangZ, etal. Nosocomial infection among patients with COVID-19: aretrospective data analysis of 918 cases from asingle center in Wuhan, China. Infect Control Hosp Epidemiol. 2020;41(8):982–983.
   PubMed Web of Science ®Google Scholar
• LuR, ZhaoX, LiJ, etal. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar
• LiX, WangW, ZhaoX, etal. Transmission dynamics and evolutionary history of 2019-nCoV. JMed Virol. 2020;92(5):501–511.
   Web of Science ®Google Scholar
• SharpeHR, GilbrideC, AllenE, etal. The early landscape of COVID-19 vaccine development in the UK and rest of the world. Immunology. 2020;160(3):223–232.
   PubMed Web of Science ®Google Scholar